<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">337852</id>
  <title nil="true"/>
  <common-name>3-amino-n-(4-chlorophenyl)-6-(4-prop-2-enoxyphenyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide</common-name>
  <description>3-amino-n-(4-chlorophenyl)-6-(4-prop-2-enoxyphenyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide is a chemical compound with the formula C24H17ClF3N3O2S. With an average molecular weight of 503.90 g/mol, 3-amino-n-(4-chlorophenyl)-6-(4-prop-2-enoxyphenyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide is a heavy molecule.</description>
  <cas>609794-49-2</cas>
  <pubchem-id>3764302</pubchem-id>
  <chemical-formula>C24H17ClF3N3O2S</chemical-formula>
  <weight>503.9</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T20:49:36Z</created-at>
  <updated-at type="dateTime">2026-08-30T20:49:36Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C=CCOC1=CC=C(C=C1)C2=NC3=C(C(=C2)C(F)(F)F)C(=C(S3)C(=O)NC4=CC=C(C=C4)Cl)N</moldb-smiles>
  <moldb-formula>C24H17ClF3N3O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C24H17ClF3N3O2S/c1-2-11-33-16-9-3-13(4-10-16)18-12-17(24(26,27)28)19-20(29)21(34-23(19)31-18)22(32)30-15-7-5-14(25)6-8-15/h2-10,12H,1,11,29H2,(H,30,32)</moldb-inchi>
  <moldb-inchikey>BAHUIMFASSBBPE-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">503.0682101</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM333745</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-amino-n-(4-chlorophenyl)-6-(4-prop-2-enoxyphenyl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0288281</sync-id>
  <structure-inchikey>BAHUIMFASSBBPE-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>8000020020000000000020000001000000800000000002001000100000002000000000000022000000001000000000000010020000010000000000004080000000000000000000200000100003000002000000000000000400000140800000100000001000008000080010080000000008040000000000000000002204000000000000000000808010000000000000000000000000000000000000000000000002000800000000000200000c4000000000000000000010000000000000000000000000040000000010000000000000000200000000000000008000000081000040000008000400800000100010209000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBoAAAAAwICBgBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:38:48Z</structure-indexed-at>
</compound>
